Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes.

Jie Sun Zekun LiGang LiHuang Kun Di AiGuoqing LiuWanru Yao Xingjuan XieHao GuYingzi ZhenZhenping Chen Runhui Wu

Published in: Research and practice in thrombosis and haemostasis (2022)

mutation were a key predictor of outcomes for low-dose ITI in children with SHA with high-titer inhibitors. It can help to stratify the prognosis and guide clinical decisions.

Keyphrases

low dose
young adults
high dose
early onset